Company Profile For Quest Diagnostics, Inc.

Quest Diagnostics, Inc. (DGX.N) (New York Stock Exchange)
sector: Healthcare · industry: Healthcare Facilities ·
As of  27 Nov 2009
58.27USD
Price Change
-0.77
Percent Change
-1.30%
 
 
Research a stock:   symbol lookup

Overview

Quest Diagnostics Incorporated is a provider of diagnostic testing, information and services. The Company offers United States patients and physicians the access to diagnostic testing services through its network of laboratories and Company-owned patient service centers. It is a provider of clinical testing, including gene-based and other esoteric testing, anatomic pathology services, including dermatopathology and testing for drugs-of-abuse, and provider of risk assessment services for the life insurance industry. The Company is also the provider of testing for clinical trials. Its diagnostics products business manufactures and markets diagnostic test kits and point-of-care testing. During the year ended December 31, 2008, the Company’s clinical testing business accounted for greater than 90% of its net revenues, with the balance derived from insurer services, clinical trials testing, diagnostic products and healthcare information technology.

Quick Financial Synopsis

BRIEF: For the nine months ended 30 September 2009, Quest Diagnostics Incorporated's revenues increased 3% to $5.61B. Net income from continuing operations increased 19% to $548.6M. Revenues reflect an increase in the demand of Clinical Laboratory Testing Business. Net income also reflects a decrease in amortization of intangible assets, lower net interest expense and higher other operating income.

Company Address

Quest Diagnostics, Inc.
3 Giralda Farms
Madison   NJ   07940
P: +1201.3935000
F: +1201.4624169

Total Employees

42800

Find Out More About DGX.N

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement